Peter J Godolphin (P J Godolphin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

PloS one

Research synthesis methods

European stroke journal

Nature medicine

University College London

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Sep 25o 2019

United Kingdom

Research Fellow :: Medical Research Council Clinical Trials Unit at UCL

Publications

Andreas Gkikas, Christos Kakos, Savvas Lampridis, Peter J Godolphin, Davide Patrini
Preoperative prognostic factors for 5-year survival following pulmonary metastasectomy from colorectal cancer: a systematic review and meta-analysis. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 63 (3) (2023)
Peter J Godolphin, Nadine Marlin, Chantelle Cornett, David J Fisher, Jayne F Tierney, Ian R White, Ewelina Rogozińska
Use of multiple covariates in assessing treatment-effect modifiers: A methodological review of individual participant data meta-analyses. Research synthesis methods (2023)
Peter J Godolphin, Philip M Bath, Alan A Montgomery
Should we adjudicate outcomes in stroke trials? A systematic review. International journal of stroke : official journal of the International Stroke Society (2022)
Peter J Godolphin, David J Fisher, Lindsay R Berry, Lennie P G Derde, Janet V Diaz, Anthony C Gordon, Elizabeth Lorenzi, John C Marshall, Srinivas Murthy, Manu Shankar-Hari, Jonathan A C Sterne, Jayne F Tierney, Claire L Vale
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis. PloS one 17 (7) (2022)
Peter J Godolphin, Ian R White, Jayne F Tierney, David J Fisher
Estimating interactions and subgroup-specific treatment effects in meta-analysis without aggregation bias: A within-trial framework. Research synthesis methods (2022)
Peter J Godolphin, Ewelina Rogozińska, David J Fisher, Claire L Vale, Jayne F Tierney
Meta-analyses based on summary data can provide timely, thorough and reliable evidence: don't dismiss them yet. Nature medicine 28 (3) (2022)
Kylie Elizabeth Hunter, Angela C Webster, Mike Clarke, Matthew J Page, Sol Libesman, Peter J Godolphin, Mason Aberoumand, Larysa H M Rydzewska, Rui Wang, Aidan Christopher Tan, Wentao Li, Ben W Mol, Melina Willson, Vicki Brown, Talia Palacios, Anna Lene Seidler
Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: Protocol for a modified e-Delphi study. PloS one 17 (10) (2022)
Jayne F Tierney, David J Fisher, Claire L Vale, Sarah Burdett, Larysa H M Rydzewska, Ewelina Rogozińska, Peter J Godolphin, Ian R White, Mahesh K B Parmar
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials. PLoS medicine 18 (5) (2021)
Peter J Godolphin, Philip M Bath, Ale Algra, Eivind Berge, John Chalmers, Misha Eliasziw, Graeme J Hankey, Naohisa Hosomi, Annamarei Ranta, Christian Weimar, Lisa J Woodhouse, Alan A Montgomery
Cost-benefit of outcome adjudication in nine randomised stroke trials. Clinical trials (London, England) 17 (5) (2020)
Peter J Godolphin, Philip M Bath, Christopher Partlett, Eivind Berge, Martin M Brown, Misha Eliasziw, Per Morten Sandset, Joaquín Serena, Alan A Montgomery
Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification. European stroke journal 5 (2) (2020)
Peter J Godolphin, Philip M Bath, Alan A Montgomery
Short email with attachment versus long email without attachment when contacting authors to request unpublished data for a systematic review: a nested randomised trial. BMJ open 9 (1) (2019)
Peter J Godolphin, Alan A Montgomery, Lisa J Woodhouse, Daniel Bereczki, Eivind Berge, Rónán Collins, Exuperio Díez-Tejedor, John Gommans, Kennedy R Lees, Serefnur Ozturk, Stephen Phillips, Stuart Pocock, Kameshwar Prasad, Szabolcs Szatmari, Yongjun Wang, Philip M Bath, Nikola Sprigg, null null
Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial. PloS one 13 (11) (2018)
Peter J Godolphin, E J Godolphin
Robustness of crossover trials against subject drop-out - Examples of perpetually connected designs. Statistical methods in medical research 28 (3) (2017)

Peter J Godolphin.css-eqlu8i{font-size:small;padding-left:4px;} (P J Godolphin)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter J Godolphin (P J Godolphin)